EUVIMEDEUVIMED entdecken
Crossref

Phase I and Phase II Evaluation of Novel Anticancer Agents: Are Response and Toxicity the Right Endpoints?

E.A. Eisenhauer

Onkologie · 2000

DOI: 10.1159/000055040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Onkologie, 2000. Verfasst von E.A. Eisenhauer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Eisenhauer, E. (2000). Phase I and Phase II Evaluation of Novel Anticancer Agents: Are Response and Toxicity the Right Endpoints?. Onkologie. https://doi.org/10.1159/000055040

Vancouver

Eisenhauer E. Phase I and Phase II Evaluation of Novel Anticancer Agents: Are Response and Toxicity the Right Endpoints?. Onkologie. 2000. doi:10.1159/000055040

BibTeX
@article{Eisenhauer2000,
  author = {Eisenhauer, E.A.},
  title = {Phase I and Phase II Evaluation of Novel Anticancer Agents: Are Response and Toxicity the Right Endpoints?},
  journal = {Onkologie},
  year = {2000},
  doi = {10.1159/000055040}
}
Kostenlos starten →